Now a potential new Rx is on the horizon and it is called Celotres.
The study involved excision of the keloid followed by an injection of Celotres into the epidermal/dermal junction. The recurrence rate was 19% versus the predicted rate of recurrence of over 50%.
I'll post again as we learn more.
No comments:
Post a Comment